Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Basal Cell × Biological Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vipoma 1 Uterine Cervical Dysplasia 1 Squamous Intraepithelial Lesions 1 Somatostatinoma 1 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, AIDS-Related 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Insulinoma 1 Glucagonoma 1 Gastrinoma 1 Congenital Abnormalities 1 Colonic Neoplasms 1 Carcinoma, Islet Cell 1 Carcinoma, Basal Cell 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

arsenous acid 1 Tomography, Optical Coherence 1 Melphalan 1 Itraconazole 1 Dilatation and Curettage 1 Desiccation 1 Curettage 1 Chemoprevention 1 Celecoxib 1 Biological Therapy 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡